STAT+: Drug companies, patient groups urge FDA to pause commissioner’s voucher program

AI justification

FDA voucher program risks political weaponization, undermining public health integrity. | The public advocacy by patient groups and drug companies represents a positive step toward transparency and accountability in healthcare governance. However, the FDA's voucher program, if weaponized for political purposes, undermines public health integrity and regulatory independence, posing significant ethical concerns. The net judgment hinges on whether the FDA addresses these concerns with concrete acti